Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-012846
Filing Date
2024-05-10
Accepted
2024-05-10 16:05:39
Documents
1
Period of Report
2024-05-08

Document Format Files

Seq Description Document Type Size
1 form4-05102024_040522.html 4  
1 form4-05102024_040522.xml 4 5698
  Complete submission text file 0001415889-24-012846.txt   7410
Mailing Address 339 NORTH GRANADOS AVE SOLANA BEACH CA 92075
Business Address
COUGHLIN TIMOTHY (Reporting) CIK: 0001376043 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36257 | Film No.: 24934785

Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Issuer) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)